{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:00:32Z","timestamp":1790780432052,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.yexcr.2020.112241","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:54:35Z","timestamp":1598007275000},"page":"112241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma"],"prefix":"10.1016","volume":"396","author":[{"given":"Tingting","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2020.112241_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.yexcr.2020.112241_bib2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/onc.2014.136","article-title":"Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer","volume":"34","author":"Miow","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2020.112241_bib3","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Chiu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.112241_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fonc.2012.00033","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Davidson","year":"2012","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.yexcr.2020.112241_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2020.112241_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2020.112241_bib7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2174\/138945012803530044","article-title":"Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer","volume":"13","author":"Huang","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.yexcr.2020.112241_bib8","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-08-2372","article-title":"Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells","volume":"15","author":"Li","year":"2009","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2020.112241_bib9","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1158\/1078-0432.CCR-06-0038","article-title":"Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines","volume":"12","author":"Yang","year":"2006","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2020.112241_bib10","doi-asserted-by":"crossref","first-page":"55543","DOI":"10.18632\/oncotarget.10837","article-title":"A FASN-TGF-beta1-FASN regulatory loop contributes to high EMT\/metastatic potential of cisplatin-resistant non-small cell lung cancer","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.112241_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-9966-33-54","article-title":"miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1","volume":"33","author":"Ma","year":"2014","journal-title":"J. Exp. Clin. Canc. Res. : CR (Clim. Res.)"},{"key":"10.1016\/j.yexcr.2020.112241_bib12","article-title":"Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets","volume":"5","author":"Wang","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2020.112241_bib13","first-page":"259","article-title":"Oncomirs - microRNAs with a role in cancer, Nature reviews","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2020.112241_bib14","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1261\/rna.1162708","article-title":"Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state","volume":"14","author":"Lin","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.yexcr.2020.112241_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nbt.1535","article-title":"Embryonic stem cell-specific microRNAs promote induced pluripotency","volume":"27","author":"Judson","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2020.112241_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/emboj.2010.319","article-title":"A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation","volume":"30","author":"Rosa","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2020.112241_bib17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/nar\/gkq850","article-title":"Regulation of somatic cell reprogramming through inducible mir-302 expression","volume":"39","author":"Lin","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2020.112241_bib18","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/ijc.29606","article-title":"Expression of the miR-302\/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes","volume":"137","author":"Yang","year":"2015","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.yexcr.2020.112241_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biocel.2016.11.004","article-title":"Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer","volume":"81","author":"Maadi","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2020.112241_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.18632\/oncotarget.6381","article-title":"miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response","volume":"7","author":"Cataldo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.112241_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ygyno.2015.11.034","article-title":"miR-302a\/b\/c\/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells","volume":"141","author":"Wang","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2020.112241_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13046-016-0300-8","article-title":"MiR-302a\/b\/c\/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP\/ERK kinase kinase 1 (MEKK1)","volume":"35","author":"Zhao","year":"2016","journal-title":"J. Exp. Clin. Canc. Res. : CR (Clim. Res.)"},{"key":"10.1016\/j.yexcr.2020.112241_bib23","first-page":"2209","article-title":"MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1, Cellular physiology and biochemistry","volume":"34","author":"Ge","year":"2014","journal-title":"international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.yexcr.2020.112241_bib24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1091\/mbc.e11-11-0965","article-title":"Regulation of Wnt signaling by the tumor suppressor adenomatous polyposis coli does not require the ability to enter the nucleus or a particular cytoplasmic localization","volume":"23","author":"Roberts","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2020.112241_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2016.01.009","article-title":"Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism","volume":"373","author":"Ai","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.yexcr.2020.112241_bib26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2020.112241_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2014.10.028","article-title":"Treatment of ovarian cancer in the older woman","volume":"136","author":"Tew","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2020.112241_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"Platinum resistant\" ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2020.112241_bib29","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2020.112241_bib30","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1158\/0008-5472.CAN-10-2746","article-title":"MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4\/6 cell cycle pathways","volume":"70","author":"Lin","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2020.112241_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drup.2010.07.001","article-title":"Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance","volume":"13","author":"Wang","year":"2010","journal-title":"Drug Resist. Updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.yexcr.2020.112241_bib32","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2020.112241_bib33","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1158\/0008-5472.CAN-14-0110","article-title":"The TGFbeta-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors","volume":"74","author":"Izumchenko","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2020.112241_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopha.2013.12.002","article-title":"MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation","volume":"68","author":"Li","year":"2014","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.yexcr.2020.112241_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cas.13104","article-title":"miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells","volume":"108","author":"Song","year":"2017","journal-title":"Canc. Sci."},{"key":"10.1016\/j.yexcr.2020.112241_bib36","doi-asserted-by":"crossref","first-page":"24510","DOI":"10.18632\/oncotarget.8229","article-title":"miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.112241_bib37","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.18632\/oncotarget.7618","article-title":"Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer","volume":"7","author":"Dwivedi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.112241_bib38","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/onc.2010.259","article-title":"Functional characterization of ATAD2 as a new cancer\/testis factor and a predictor of poor prognosis in breast and lung cancers","volume":"29","author":"Caron","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2020.112241_bib39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/modpathol.3800937","article-title":"Prognostic significance of drug-regulated genes in high-grade osteosarcoma","volume":"20","author":"Fellenberg","year":"2007","journal-title":"Mod. Pathol. : an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/j.yexcr.2020.112241_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2407-14-107","article-title":"miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Canc."},{"key":"10.1016\/j.yexcr.2020.112241_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.14348\/molcells.2014.0258","article-title":"Lessons from yeast on emerging roles of the ATAD2 protein family in gene regulation and genome organization","volume":"37","author":"Cattaneo","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.yexcr.2020.112241_bib42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbagrm.2013.06.003","article-title":"Malignant genome reprogramming by ATAD2","volume":"1829","author":"Boussouar","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2020.112241_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-09-0095","article-title":"Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR\/AIB1 overexpression in breast cancer","volume":"8","author":"Hsia","year":"2010","journal-title":"Mol. Canc. Res. : MCR"},{"key":"10.1016\/j.yexcr.2020.112241_bib44","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1158\/0008-5472.CAN-09-2131","article-title":"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors","volume":"69","author":"Ciro","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2020.112241_bib45","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.2147\/OTT.S237580","article-title":"Long non-coding RNA CRNDE promotes colorectal carcinoma cell progression and paclitaxel resistance by regulating miR-126-5p\/ATAD2 Axis","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.yexcr.2020.112241_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/1541-7786.MCR-13-0459","article-title":"Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance","volume":"12","author":"Zou","year":"2014","journal-title":"Mol. Canc. Res. : MCR"},{"key":"10.1016\/j.yexcr.2020.112241_bib47","first-page":"219","article-title":"ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation","volume":"56","author":"Liu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2020.112241_bib48","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.7314\/APJCP.2014.15.6.2777","article-title":"ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis","volume":"15","author":"Wan","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP : Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.yexcr.2020.112241_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2020.112241_bib50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cam4.1040","article-title":"GOLPH3 induces epithelial-mesenchymal transition via Wnt\/beta-catenin signaling pathway in epithelial ovarian cancer","volume":"6","author":"Sun","year":"2017","journal-title":"Cancer medicine"},{"key":"10.1016\/j.yexcr.2020.112241_bib51","doi-asserted-by":"crossref","first-page":"23720","DOI":"10.18632\/oncotarget.4690","article-title":"Critical role of Wnt\/beta-catenin signaling in driving epithelial ovarian cancer platinum resistance","volume":"6","author":"Nagaraj","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2020.112241_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12931-017-0537-6","article-title":"ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling","volume":"18","author":"Vesel","year":"2017","journal-title":"Respir. Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720304900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720304900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:32:24Z","timestamp":1757997144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482720304900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0014482720304900"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.112241","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.112241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112241"}}